◆英語タイトル:VWR International LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013524
◆発行会社(調査会社):
GlobalData
◆発行日:2017年11月28日
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
VWR International LLC (VWR) a subsidiary of VWR Corp is a supplier of products, services and solutions to laboratories. The company’s business areas comprise differentiated services, product choice and operational excellence. Its product choice services include supply of beakers, freezers, biochemicals, reagents and sera among others. VWR also provides custom manufacturing, catalyst laboratory, technology solutions and support to research and laboratory operations. Its technology services include electronic data exchange, file transfer, and apps for electronic devices. The company serves only pharmaceutical, biotechnology, industrial, education, government and healthcare industries. It has its operations in the Americas, Europe, Asia and Africa. VWR is headquartered in Radnor, Pennsylvania, the US.
VWR International LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
VWR International LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
VWR International LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
VWR International LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
VWR International LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
VWR International LLC, Medical Devices Deals, 2011 to YTD 2017 9
VWR International LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
VWR International LLC, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
VWR International Enters Into Distribution Agreement With Thermo Fisher Scientific 11
Debt Offering 12
VWR Completes Private Placement Of Notes Due 2017 For US$750 Million 12
Acquisition 13
VWR International Acquires Reliable Biopharma and BioArra 13
VWR International Acquires Therapak, and Therapak Pharma Services 14
VWR International Acquires National Biochemicals 15
VWR International Acquires LABRepCo 16
VWR International To Acquire Peqlab Biotech 17
VWR International Acquires United Biochemicals 18
VWR International Acquires Prolab Laboratuar Teknolojileri, Scientific Lab Supplies Distributor 19
VWR International Acquires Lab3, Scientific Laboratory Products Distributor 20
VWR International Acquires Sovereign, Laboratory Products Distributor 21
VWR International Acquires INTERNATIONAL P.B.I. 22
VWR International To Acquire LabPartner 23
VWR International Acquires AMRESCO 24
VWR International LLC – Key Competitors 25
VWR International LLC – Key Employees 26
VWR International LLC – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 29
Strategy And Business Planning 29
Aug 22, 2017: VWR Showcases New 125,000 Square Foot Regional Distribution Center 29
Government and Public Interest 30
Mar 13, 2017: The VWR Foundation Advances Science with Over $129,000 in First Quarter Grants 30
Other Significant Developments 31
Jul 20, 2016: SGI-DNA, A Synthetic Genomics Company, Announces Exclusive Global Distribution Agreement for Reagents with VWR 31
Jun 06, 2016: Improving the Customer Experience Through Enhanced Technology 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33
List of Tables
VWR International LLC, Pharmaceuticals & Healthcare, Key Facts 2
VWR International LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
VWR International LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
VWR International LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
VWR International LLC, Deals By Therapy Area, 2011 to YTD 2017 8
VWR International LLC, Medical Devices Deals, 2011 to YTD 2017 9
VWR International LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
VWR International Enters Into Distribution Agreement With Thermo Fisher Scientific 11
VWR Completes Private Placement Of Notes Due 2017 For US$750 Million 12
VWR International Acquires Reliable Biopharma and BioArra 13
VWR International Acquires Therapak, and Therapak Pharma Services 14
VWR International Acquires National Biochemicals 15
VWR International Acquires LABRepCo 16
VWR International To Acquire Peqlab Biotech 17
VWR International Acquires United Biochemicals 18
VWR International Acquires Prolab Laboratuar Teknolojileri, Scientific Lab Supplies Distributor 19
VWR International Acquires Lab3, Scientific Laboratory Products Distributor 20
VWR International Acquires Sovereign, Laboratory Products Distributor 21
VWR International Acquires INTERNATIONAL P.B.I. 22
VWR International To Acquire LabPartner 23
VWR International Acquires AMRESCO 24
VWR International LLC, Key Competitors 25
VWR International LLC, Key Employees 26
VWR International LLC, Subsidiaries 27